SanBio Co. Ltd. | Ownership
Companies that own SanBio Co. Ltd.
JPMorgan Asset Management (Japan) Ltd.
1,823,300
3.67%
-478,600
0.5%
02/15/2018
Baillie Gifford & Co.
1,157,600
2.33%
44,900
0.03%
04/30/2018
RBC Investment Management (Asia) Ltd.
600,000
1.21%
-38,800
0.88%
12/31/2017
Comgest SA
452,100
0.91%
68,300
0.08%
05/31/2018
Asset Management One Co., Ltd.
263,398
0.53%
151,498
0.01%
03/05/2018
AXA Investment Managers UK Ltd.
151,000
0.3%
0
0.02%
02/15/2018
BlackRock Fund Advisors
117,100
0.24%
0
0%
09/06/2018
Eaton Vance Management
92,232
0.19%
92,232
0.01%
06/30/2018
Sawakami Asset Management, Inc.
68,499
0.14%
68,499
0.1%
08/23/2017
JPMorgan Asset Management (UK) Ltd.
62,700
0.13%
62,700
0%
12/31/2017
| Address |
St. Luke Tower, 28/F
Tokyo Tokyo 104
Japan
|
|
Employees
|
- |
| Website |
http://www.sanbio.jp |
| Updated |
07/08/2019 |
| SanBio Co., Ltd. engages in the development and sale of regenerative cells pharmaceuticals. It also provides regenerative therapies for neurological disorders that include stroke, traumatic brain injury, eye diseases, and Parkinson's disease. The company was founded by Keita Mori and Toru Kawanishi in February 2001 and is headquartered in Tokyo, Japan. |
